Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · IEX Real-Time Price · USD
0.675
-0.008 (-1.20%)
At close: Apr 17, 2024, 3:58 PM
0.701
+0.026 (3.88%)
After-hours: Apr 17, 2024, 7:28 PM EDT
Company Description
Newcourt Acquisition Corp does not have significant operations.
It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
Newcourt Acquisition Corp was incorporated in 2021 and is based in Oakland, California. Newcourt Acquisition Corp operates as a subsidiary of Newcourt SPAC Sponsor LLC.
Psyence Biomedical Ltd.
| Country | Ontario, Canada |
| Founded | 1994 |
| Industry | Shell Companies |
| Sector | Financials |
Contact Details
Address: 121 Richmond Street West Penthouse, Suite 1300 Toronto, A6 M5H 2K1 Ontario, Canada | |
| Phone | 27744604171 |
| Website | psyence.com |
Stock Details
| Ticker Symbol | PBM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001985062 |
| ISIN Number | KYG6448C1033 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Marc Gregory Balkin | Chief Executive Officer and Director |
| Jurgen Van De Vyver | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 15, 2024 | 6-K | Report of foreign issuer |
| Mar 12, 2024 | 6-K | Report of foreign issuer |
| Feb 9, 2024 | F-1 | Registration statement for certain foreign private issuers |
| Feb 5, 2024 | SC 13D | General statement of acquisition of beneficial ownership |
| Feb 5, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Jan 31, 2024 | 20-F | Annual and transition report of foreign private issuers |
| Jan 26, 2024 | CERT | Certification by an exchange approving securities for listing |
| Jan 25, 2024 | 8-A12B | Registration of securities |
| Nov 15, 2023 | 424B3 | Prospectus |
| Nov 13, 2023 | EFFECT | Notice of Effectiveness |